| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 21/10/2014 | 14h00 | PR Newswire (US) | Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTO | AMEX:LRP | Lorus Therapeutics, (New) |
| 21/10/2014 | 14h00 | PR Newswire (Canada) | Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTO | AMEX:LRP | Lorus Therapeutics, (New) |
| 03/10/2014 | 13h00 | PR Newswire (US) | Aptose Biosciences to Present at the 2014 BIO Investor Forum | AMEX:LRP | Lorus Therapeutics, (New) |
| 03/10/2014 | 13h00 | PR Newswire (Canada) | Aptose Biosciences to Present at the 2014 BIO Investor Forum | AMEX:LRP | Lorus Therapeutics, (New) |
| 01/10/2014 | 23h16 | PR Newswire (Canada) | Aptose Biosciences Announces Reverse Stock Split | AMEX:LRP | Lorus Therapeutics, (New) |
| 01/10/2014 | 23h16 | PR Newswire (US) | Aptose Biosciences Announces Reverse Stock Split | AMEX:LRP | Lorus Therapeutics, (New) |
| 29/09/2014 | 14h30 | PR Newswire (US) | Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & S... | AMEX:LRP | Lorus Therapeutics, (New) |
| 29/09/2014 | 14h30 | PR Newswire (Canada) | Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & S... | AMEX:LRP | Lorus Therapeutics, (New) |
| 25/09/2014 | 15h48 | PR Newswire (US) | Aptose Biosciences to Present at Upcoming Investor Conferences | AMEX:LRP | Lorus Therapeutics, (New) |
| 25/09/2014 | 15h48 | PR Newswire (Canada) | Aptose Biosciences to Present at Upcoming Investor Conferences | AMEX:LRP | Lorus Therapeutics, (New) |
| 08/09/2014 | 13h00 | PR Newswire (US) | Aptose Biosciences Recruits Stephen B. Howell, M.D. to Act in the Capacity of Chief Medical Officer | AMEX:LRP | Lorus Therapeutics, (New) |
| 08/09/2014 | 13h00 | PR Newswire (Canada) | Aptose Biosciences Recruits Stephen B. Howell, M.D. to Act in the Capacity of Chief Medical Officer | AMEX:LRP | Lorus Therapeutics, (New) |
| 02/09/2014 | 13h00 | PR Newswire (US) | Lorus Therapeutics Implements Name Change to Aptose Biosciences | AMEX:LRP | Lorus Therapeutics, (New) |
| 02/09/2014 | 13h00 | PR Newswire (Canada) | Lorus Therapeutics Implements Name Change to Aptose Biosciences | AMEX:LRP | Lorus Therapeutics, (New) |
| 19/08/2014 | 22h00 | PR Newswire (US) | Lorus Therapeutics Announces Results of Annual and Special Meeting of Shareholders | AMEX:LRP | Lorus Therapeutics, (New) |
| 19/08/2014 | 22h00 | PR Newswire (Canada) | Lorus Therapeutics Announces Results of Annual and Special Meeting of Shareholders | AMEX:LRP | Lorus Therapeutics, (New) |
| 07/08/2014 | 13h00 | PR Newswire (US) | Lorus Therapeutics to Present at the Canaccord Genuity 34th Annual Growth Conference | AMEX:LRP | Lorus Therapeutics, (New) |
| 07/08/2014 | 13h00 | PR Newswire (Canada) | Lorus Therapeutics to Present at the Canaccord Genuity 34th Annual Growth Conference | AMEX:LRP | Lorus Therapeutics, (New) |
| 28/07/2014 | 13h00 | PR Newswire (US) | Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blo... | AMEX:LRP | Lorus Therapeutics, (New) |
| 28/07/2014 | 13h00 | PR Newswire (Canada) | Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blo... | AMEX:LRP | Lorus Therapeutics, (New) |
| 15/07/2014 | 22h46 | PR Newswire (US) | Lorus Therapeutics Reports Results for the Fourth Quarter and Full Year Ended May 31, 2014 | AMEX:LRP | Lorus Therapeutics, (New) |
| 15/07/2014 | 22h46 | PR Newswire (Canada) | Lorus Therapeutics Reports Results for the Fourth Quarter and Full Year Ended May 31, 2014 | AMEX:LRP | Lorus Therapeutics, (New) |
| 15/07/2014 | 22h28 | PR Newswire (US) | Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ Listing | AMEX:LRP | Lorus Therapeutics, (New) |
| 15/07/2014 | 22h28 | PR Newswire (Canada) | Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ Listing | AMEX:LRP | Lorus Therapeutics, (New) |
| 10/07/2014 | 13h00 | PR Newswire (US) | Lorus Therapeutics To Host Fourth Quarter and Year End 2014 Financial Results Conference Call and Webcast | AMEX:LRP | Lorus Therapeutics, (New) |
| 10/07/2014 | 13h00 | PR Newswire (Canada) | Lorus Therapeutics To Host Fourth Quarter and Year End 2014 Financial Results Conference Call and Webcast | AMEX:LRP | Lorus Therapeutics, (New) |
| 19/06/2014 | 13h00 | PR Newswire (US) | Lorus Therapeutics to Present at the 9th JMP Securities Healthcare Conference | AMEX:LRP | Lorus Therapeutics, (New) |
| 19/06/2014 | 13h00 | PR Newswire (Canada) | Lorus Therapeutics to Present at the 9th JMP Securities Healthcare Conference | AMEX:LRP | Lorus Therapeutics, (New) |
| 16/06/2014 | 13h00 | PR Newswire (Canada) | Lorus Therapeutics to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference | AMEX:LRP | Lorus Therapeutics, (New) |
| 16/06/2014 | 13h00 | PR Newswire (US) | Lorus Therapeutics to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference | AMEX:LRP | Lorus Therapeutics, (New) |